ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

LUCD Lucid Diagnostics Inc

0.92
0.005 (0.55%)
After Hours
Last Updated: 17:56:44
Delayed by 15 minutes

Period:

Draw Mode:

Volume 120,420
Bid Price 0.9003
Ask Price 0.9292
News -
Day High 0.93

Low
0.6301

52 Week Range

High
1.85

Day Low 0.90
Share Name Share Symbol Market Stock Type
Lucid Diagnostics Inc LUCD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.005 0.55% 0.92 17:56:44
Open Price Low Price High Price Close Price Previous Close
0.9149 0.90 0.93 0.93 0.915
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
368 120,420 US$ 0.9143839 US$ 110,110 - 0.6301 - 1.85
Last Trade Type Quantity Price Currency
17:59:57 15 US$ 0.9003 USD

Lucid Diagnostics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
41.54M 44.67M - 2.43M -52.67M -1.18 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lucid Diagnostics News

Date Time Source News Article
5/14/202405:05Edgar (US Regulatory)Form 8-K - Current report
5/13/202419:43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024..
5/13/202407:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202407:00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter..
5/09/202420:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/09/202420:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/09/202406:49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device..
5/08/202415:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/08/202415:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/07/202406:50Edgar (US Regulatory)Form 8-K - Current report
5/07/202406:39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock..
5/02/202407:35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LUCD Message Board. Create One! See More Posts on LUCD Message Board See More Message Board Posts

Historical LUCD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.890.94490.8763510.9115647129,9140.033.37%
1 Month0.6751.110.63010.9184649256,5570.24536.30%
3 Months1.281.320.63010.9460719227,733-0.36-28.13%
6 Months1.331.580.63011.04141,029-0.41-30.83%
1 Year1.541.850.63011.1494,280-0.62-40.26%
3 Years12.7513.500.63013.47124,116-11.83-92.78%
5 Years12.7513.500.63013.47124,116-11.83-92.78%

Lucid Diagnostics Description

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.